Goldman Sachs

Goldman Sachs Beats on Strong Investing, Lending; Lower Costs

Goldman Sachs Group, Inc. (NYSE:GS) reported EPS of $4.29, beating Street estimates of $3.87, due to stronger revenues (particularly in investing & lending) and better non-comp expenses. Top-line results  for Goldman Sachs Group, Inc. (NYSE:GS) were better than expected (+9% q/q and flat y/y ex DVA) and expenses came in lower than expected (though +36% q/q, given 4Q comp true-up), with a comp ratio of 43% and non-comp -19% q/q and -1% y/y.

Goldman Sachs Beats on Strong Investing, Lending; Lower Costs

Mgmt bought back 10.1M shares and upped the authorization to 86.4M shares, and capital ratios remain strong, with a 12.7% Tier 1 Common Ratio. The ROE for the quarter was 12.4% (13.2% ROTE) and BV/TBV grew at 3% q/q. Overall, a strong quarter, and while some of the strength in revenues was driven by marks (I&L), mgmt continues to focus on what they can control (costs and capital mgmt).

Segment Data via Citi

FICC weaker & Expense change mostly a timing issue – Overall, we view 1Q core results as mostly inline with our above-consensus estimates. 1Q’s softer FICC performance may set up for a bit softer 2013 given Goldman Sachs Group, Inc. (NYSE:GS)’s seasonal pattern of sequential revenue declines throughout the year. Overall, we see the comp ratio cut to 43% as more of a quarterly timing issue that mostly reduces flexibility for the rest of the year, and should not significantly impact our full year estimates, given we already are modeling 39% for 2013 & 2014. This is also not the 1st time GS accrued 43% in 1Q (1Q10 as well).

Softer FICC for Goldman Sachs Group, Inc. (NYSE:GS) offset by better Inv Banking; Equities Inline — Core FICC revenues (ex DVA) of $3.26 bil missed our $3.56 bil estimate, falling -9% y/y (vs our flat est) due we think to weaker Rates (which had a strong quarter last year due to LTRO), though core Equities revenues of $1.96 bil were just ahead of our $1.91 bil estimate, falling – 17% y/y driven by a -23% drop in Eq client execution. I-banking was key bright spot rising 36% y/y beating our estimate by ~$250 mil on 69% y/y rise in DCM, and 53% increase in ECM.

Inv & Lending a bit better across the board; Inv Mgmt also slightly better — I&L was a ~$300 mil beat as Equity gains were ~$90 mil better than expected plus smaller beats in Debt, ICBC & Other. Inv Mgmt revs beat us by $90 mil on incentive fees and AUM rose 1% q/q to $860B with $11B of l/t inflows offset by $15B of liquidity outflows.

Goldman Sachs Group, Inc. (NYSE:GS) Capital remains solid, VaR flat — TBV/shr rose +3% q/q to $139 and GS bought back $1.52 bil of stock in the qtr (vs our $1.4 bil est). Firmwide assets rose 2% q/q to $959 billion. VaR was flat q/q at $76 mil. Board approved 75 mil shr buyback authorization.

Positives and Negatives for Goldman Sachs Group, Inc. (NYSE:GS) Via BAML

  1. Investment banking +12% q/q (+36% y/y) with ECM +28% q/q (+53% y/y), and record DCM revs +17% q/q (+69% y/y);
  2. Total trading (ex DVA and the 4Q HF admin sale) +31% q/q; with FICC trading +54% q/q & equity trading +6% q/q (equity client execution +4% q/q, commissions +10% q/q, and security services +1% q/q);
  3. Investing & lending revenues of $2.1B (+5% q/q) on broad strength;
  4. Inv mgmt LT inflows of $11B;
  5. VaR flat q/q;
  6. Non-comp expenses -19% q/q and -1% y/y and comp ratio inline;
  7. Headcount -1% q/q & y/y;
  8. BV/TBV +3% q/q and +10%/+12% y/y;
  9. Strong Tier 1 Common Ratio of 12.7% under revised regulations, and $174B GCE;
  10. Buybacks of 10.1M shares (vs. 12.7M in 4Q), and upped authorization to 86.4M shares; &
  11. ROE of 12.4% (16.5% in 4Q given comp true-up) & ROTE of 13.2%.

Negatives in the quarter for Goldman Sachs Group, Inc. (NYSE:GS)

  1. M&A -5% q/q (-1% y/y), & IB backlog lower.
  2. Total trading (ex DVA) -12% y/y, with FICC trading -9% y/y & equity trading -17% y/y;
  3. Investment mgmt revs down 13% q/q, given seasonally weaker performance fees ($140M vs. $344M in 4Q);
  4. Small DVA loss of $77M;
  5. Share count ticked higher q/q; &
  6. Macro & regulatory headwinds remain.

LEAVE A COMMENT


X
Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Are you an intelligent investor?

ValueWalkPremium is a website and newsletter for smart investors like yourself. We focus on the latest hedge fund industry news much of which is not in the public domain and obtained via our sources.

We also have 10 years of resources on how to use this information to better your investment process.

Sign up for  today for only a few dollars a day and get a 3 day no obligation trial with a targeted 20% discount coupon code.

Cancel anytime during trial and you are never charged.

Limited time offer: For first 50 subscribers

0